Product Code: SR112025A6157
The global advanced wound care market size reached USD 11.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. Various factors including rising incidence of chronic wounds, ongoing technological advancements, and increasing surgical procedures are propelling the market. In addition, the growing number of complex surgeries like orthopedic, cardiovascular, and neurological surgeries, is also driving the market growth.
Advanced wound care is a standard medical solution that provides specialized treatment for chronic infections and non-healing wounds by removing dead and inflamed tissues. It includes medications, equipment, and several products that help treat acute and chronic wounds, such as burns, ulcers, and post-operative wounds. Advanced wound care products comprising silver and alginates are extensively used to remove excess fluids from wounds and protect them from infections. They include hydrogels, hydrocolloids, film and foam dressings, and alginates. They help retain skin moisture and facilitate quick healing of wounds internally and externally by promoting the growth of body cells.
Advanced Wound Care Market Trends:
The increasing global geriatric population and the rising prevalence of pressure ulcers, diabetic foot ulcers, and other chronic wounds are among the key factors positively influencing the market. Chronic wounds are complex and non-healing infections that fail to progress through the healing phases in an orderly sequence. In addition, the increasing occurrence of diabetes, obesity, and a significant surge in the need for surgical procedures across the globe are catalyzing the demand for advanced wound care products as they help absorb necrotic tissues, which are highly effective in the rapid healing of surgical site infections. In line with this, the rising awareness among individuals about the proven benefits and effectiveness of these products is increasing their sales worldwide. Apart from this, technological advancements in advanced wound care products are contributing to market growth. For instance, nanoparticle-based wound healing and skin regeneration bioactive molecules over the applied area maintain the drug release and improve the therapeutic effects of drugs. Furthermore, the expansion of Ambulatory Surgical Centers (ASCs) that provide diagnostics, preventive procedures, and surgical care for pain management, orthopedics, urology, restorative, organ transplantation, and reconstructive surgeries, is propelling the market growth.
Key Market Segmentation:
Breakup by Product:
- Infection Management
- Silver Wound Dressings
- Non-silver Dressings
- Collagen Dressings
- Exudate Management
- Hydrocolloids Dressings
- Foam Dressings
- Alginate Dressings
- Hydrogel Dressings
- Active Wound Care
- Skin Substitutes
- Growth Factors
- Therapy Devices
- Negative Pressure Wound Therapy (NPWT)
- Oxygen and Hyperbaric Oxygen Equipment
- Electromagnetic Therapy Devices
- Others
Breakup by Application:
- Chronic Wounds
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Arterial Ulcers
- Acute Wounds
- Burns and Trauma
- Surgical Wounds
Breakup by End User:
- Hospitals
- Community Health Service Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, B. Braun SE (B. Braun Holding GmbH & Co. KG), Cardinal Health, Inc., Coloplast A/S, Convatec Group plc, Essity AB, Integra LifeSciences, Medline Industries, LP, Medtronic plc, Molnlycke Health Care (Investor AB), Organogenesis Holdings Inc. and Smith & Nephew plc.
Key Questions Answered in This Report
- 1.What was the size of the global advanced wound care market in 2024?
- 2.What is the expected growth rate of the global advanced wound care market during 2025-2033?
- 3.What are the key factors driving the global advanced wound care market?
- 4.What has been the impact of COVID-19 on the global advanced wound care market?
- 5.What is the breakup of the global advanced wound care market based on the application?
- 6.What is the breakup of the global advanced wound care market based on the end user?
- 7.What are the key regions in the global advanced wound care market?
- 8.Who are the key players/companies in the global advanced wound care market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Advanced Wound Care Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Infection Management
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Silver Wound Dressings
- 6.1.2.2 Non-silver Dressings
- 6.1.2.3 Collagen Dressings
- 6.1.3 Market Forecast
- 6.2 Exudate Management
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Hydrocolloids Dressings
- 6.2.2.2 Foam Dressings
- 6.2.2.3 Alginate Dressings
- 6.2.2.4 Hydrogel Dressings
- 6.2.3 Market Forecast
- 6.3 Active Wound Care
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Skin Substitutes
- 6.3.2.2 Growth Factors
- 6.3.3 Market Forecast
- 6.4 Therapy Devices
- 6.4.1 Market Trends
- 6.4.2 Key Segments
- 6.4.2.1 Negative Pressure Wound Therapy (NPWT)
- 6.4.2.2 Oxygen and Hyperbaric Oxygen Equipment
- 6.4.2.3 Electromagnetic Therapy Devices
- 6.4.3 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Chronic Wounds
- 7.1.1 Market Trends
- 7.1.2 Key Segments
- 7.1.2.1 Pressure Ulcers
- 7.1.2.2 Diabetic Foot Ulcers
- 7.1.2.3 Venous Leg Ulcers
- 7.1.2.4 Arterial Ulcers
- 7.1.3 Market Forecast
- 7.2 Acute Wounds
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Burns and Trauma
- 7.2.2.2 Surgical Wounds
- 7.2.3 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Community Health Service Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 3M Company
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 B. Braun SE (B. Braun Holding GmbH & Co. KG)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Cardinal Health, Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Coloplast A/S
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Convatec Group plc
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Essity AB
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 Integra LifeSciences
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Medline Industries, LP
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 SWOT Analysis
- 14.3.9 Medtronic plc
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Molnlycke Health Care (Investor AB)
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 SWOT Analysis
- 14.3.11 Organogenesis Holdings Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.12 Smith & Nephew plc
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis